The North America albendazole anthelmintic drug market is expanding due to continued demand for effective antiparasitic therapies and established pharmaceutical infrastructure across the region. The US represents a major contributor to regional demand, supported by the use of albendazole for several helminth infections and the introduction of additional generic products. Increasing healthcare...